Glaukos (GKOS) Return on Capital Employed Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 252.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 23.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -110.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 49.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 658.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -231.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 200.00 |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn | -359.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -359.00 |
| Dec 31, 2025 | -130.00 |
| Sep 30, 2025 | 1,592.00 |
| Jun 30, 2025 | 1,530.00 |
| Mar 31, 2025 | 1,424.00 |
| Dec 31, 2024 | 1,129.00 |
| Sep 30, 2024 | -156.00 |
| Jun 30, 2024 | -281.00 |
| Mar 31, 2024 | -206.00 |
| Dec 31, 2023 | -596.00 |
| Sep 30, 2023 | -705.00 |
| Jun 30, 2023 | -956.00 |
| Mar 31, 2023 | -1,239.00 |
| Dec 31, 2022 | -551.00 |
| Sep 30, 2022 | -426.00 |
| Jun 30, 2022 | 380.00 |
| Mar 31, 2022 | 1,106.00 |
| Dec 31, 2021 | 969.00 |
| Mar 31, 2021 | 130.00 |
| Dec 31, 2020 | -305.00 |
| Mar 31, 2020 | -759.00 |
| Dec 31, 2019 | -223.00 |
| Sep 30, 2019 | 233.00 |
| Jun 30, 2019 | -110.00 |
| Mar 31, 2019 | -159.00 |
| Dec 31, 2018 | -600.00 |
| Sep 30, 2018 | -739.00 |
| Jun 30, 2018 | -287.00 |
| Mar 31, 2018 | -755.00 |
| Dec 31, 2017 | -541.00 |
| Sep 30, 2017 | -345.00 |
| Jun 30, 2017 | -71.00 |
| Mar 31, 2017 | 1,185.00 |
| Dec 31, 2016 | 1,433.00 |
| Sep 30, 2016 | 1,453.00 |